Mauna Kea Technologies Reports Fourth Quarter and Full Year 2020 Sales
PARIS & BOSTON–(BUSINESS WIRE)–Regulatory News:
Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced sales results for the fourth quarter and twelve months of fiscal year 2020.
Fourth Quarter of 2020 Sales Summary
- Total sales for the fourth quarter of 2020 increased €0.7 million, or 41% year-over-year, to €2.4 million
- Consumables sales decreased €0.1 million, or 5% year-over-year, to €1.0 million
- Systems sales increased €0.7 million, or 192% year-over-year, to €1.1 million
- Services sales decreased 2% year-over-year to €0.3 million
Full Year 2020…
